Ticker · CUSIP 016744500

ALLR

ALLARITY THERAPEUTICS INC
···Share
Holders (tracked)
3
Combined shares
359,695
Combined value
$388.5K
Last close
$1.23
Quarter
2025Q4
Price · 1Y$1.23+0.29 (+30.85%)H $1.97 · L $0.80 · Avg Vol 2.1M
Position opened
$1.00$1.50$2.00VolJul 25Oct 25Jan 26Apr 26
Tracked holders · last 8 quarters
Flat over the last 2 quarters.
332025Q32025Q4
Price is +13.9% vs the avg quarter-end implied price across tracked holders.

SEC event timeline

5 events
  1. −9,551 shares · 2025Q4
    Position
  2. +13,582 shares · 2025Q4
    Position
  3. +181,426 shares · 2025Q4
    Position
  4. +13,910 shares · 2025Q3
    Position
  5. +66,186 shares · 2025Q3
    Position

Insider activity

No insider transactions in the last 30 days.
Follow-the-investor returns
If you'd copied each holder of ALLR…
Cost basis inferred from each manager's quarter-over-quarter position changes. Sorted by % return on the position they're still holding.
InvestorFirst inCost basisReturnPosition value today
Renaissance Technologies2025Q3$1.21+1.3%$305K
Two Sigma Investments2025Q3$1.33-7.7%$34K
Ken Griffin (Citadel Advisors)2025Q3$1.58-22.2%$104K

Who moved on this name in 2025Q4

Position changes reported for the latest quarter, grouped by direction.
New positions0
Added to2
Trimmed1
Exited0

Institutional ownership over time

Distinct super-investors holding this ticker · combined dollar value, by quarter.
QuarterHoldersCombined value
2025Q3
3
$275K
2025Q4
3
$388K

Who owns ALLR

3 super-investors · 2025Q4
Tracked stake
359.7K
shares
Combined value
$388K
% of shares outstanding
shares-out unknown
Quarter action mix
Added2Trim1
#ManagerSharesValue
1Renaissance Technologies247.6K$267K
2Ken Griffin
Citadel Advisors
84.6K$91K
3Two Sigma Investments27.5K$30K

Recent moves

5 transactions
Embed this chart
Paste this iframe anywhere to embed the live ALLR chart.
<iframe src="https://openstocks.me/embed/stocks/ALLR" width="100%" height="480" frameborder="0" loading="lazy" title="ALLR chart by OpenStocks" style="border:0;border-radius:12px;background:transparent"></iframe>
Explore related topics